{"gene":"POLR3GL","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2013,"finding":"POLR3GL and POLR3G arose from a DNA-based gene duplication in a common ancestor of vertebrates. Both POLR3GL-containing and POLR3G-containing Pol III complexes occupy the same target genes in very constant proportions within one cell line (by ChIP-seq), indicating that the two Pol III isoforms share the same target gene specificity. The POLR3GL promoter does not bind MYC (unlike the POLR3G promoter), indicating that POLR3G and POLR3GL acquired distinct transcriptional regulatory mechanisms (neofunctionalization at the transcription unit level, not at the level of the gene product's target specificity).","method":"Genome-wide ChIP-seq, evolutionary genomic analysis, promoter-MYC binding analysis","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq with multiple orthogonal methods (ChIP-seq, evolutionary analysis, promoter binding assays) in a focused mechanistic study","pmids":["24107381"],"is_preprint":false},{"year":2019,"finding":"Depletion of POLR3GL does not trigger proliferative arrest or differentiation of prostate cancer cells, in contrast to depletion of the paralog POLR3G, demonstrating that POLR3GL and POLR3G have functionally distinct roles in controlling cancer cell fate despite both being incorporated into Pol III.","method":"siRNA depletion / knockdown with proliferation and differentiation phenotypic readouts in prostate cancer cell lines","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockdown with specific cellular phenotype readouts, single lab, two subunits compared in parallel","pmids":["30820548"],"is_preprint":false},{"year":2019,"finding":"Biallelic loss-of-function splice acceptor site variants in POLR3GL confirmed by RNA sequencing (showing loss of full-length POLR3GL transcripts) cause endosteal hyperostosis and oligodontia, establishing POLR3GL as a disease-causing subunit of the Pol III complex.","method":"Whole exome sequencing, RNA sequencing (nonsense-mediated decay / splice variant validation) in patient blood samples","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA sequencing confirmed loss-of-function at transcript level; single study but uses orthogonal molecular validation","pmids":["31089205"],"is_preprint":false},{"year":2019,"finding":"A homozygous nonsense variant in POLR3GL (p.Arg120Ter) leads to nonsense-mediated decay of POLR3GL transcripts (confirmed by RNA studies), establishing that complete loss of POLR3GL function causes a variant of neonatal progeroid syndrome.","method":"Exome sequencing and RNA analysis (NMD confirmation) in patient sample","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — RNA-level NMD confirmation in patient sample, single case report with molecular validation","pmids":["31695177"],"is_preprint":false},{"year":2020,"finding":"POLR3GL-containing Pol III (Pol IIIβ) and POLR3G-containing Pol III (Pol IIIα) bind the same target genes and perform the same function both in vitro and in vivo. POLR3GL can compensate for loss of POLR3G: exogenous POLR3GL expression rescues the differentiation defect of POLR3G knockout ESCs. POLR3GL knockout mice complete embryonic development but die at ~3 weeks after birth with growth defects and potential cerebellar neuronal defects, attributed to insufficient total Pol III rather than a unique POLR3GL function.","method":"Conditional and constitutive knockout mouse models, in vitro transcription assays, ChIP-seq, ESC differentiation rescue experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro assays, in vivo knockout models, and rescue experiments with multiple orthogonal methods in a single rigorous study","pmids":["32576691"],"is_preprint":false},{"year":2019,"finding":"During Xenopus skeletal muscle differentiation, Polr3gL (POLR3GL ortholog) is upregulated alongside contractile protein genes, whereas Polr3g is downregulated. Using a custom tRNA microarray, Polr3g and Polr3gL were shown to have distinct activities on the synthesis of specific tRNA isoacceptors. Forced Polr3g expression partially reverses myogenic differentiation, placing Pol III isoform composition as a regulatory determinant of muscle cell fate.","method":"Custom tRNA microarray, overexpression rescue experiments in Xenopus myogenic differentiation model","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional tRNA microarray plus overexpression phenotype in developmental model, single lab, two orthogonal approaches","pmids":["31173763"],"is_preprint":false},{"year":2022,"finding":"Loss of POLR3G (but not POLR3GL) results in a restricted Pol III transcriptional repertoire, with snaR-A noncoding RNA being particularly sensitive to POLR3G loss. This establishes that POLR3G-containing Pol III has enhanced transcriptional activity at a specific subset of targets compared to POLR3GL-containing Pol III, identifying Pol III isoform identity as a transcriptional regulatory mechanism.","method":"POLR3G knockout/depletion, ChIP-seq, RNA-seq, genomic analysis of Pol III isoform occupancy","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal isoform genomics with ChIP-seq and RNA-seq, multiple orthogonal methods establishing differential activity of the two isoforms","pmids":["35637192"],"is_preprint":false},{"year":2021,"finding":"POLR3GL (as RPC7β) is one of two alternate subunits that define distinct vertebrate Pol III isoforms; structural and genomic studies indicate RPC7β (POLR3GL) confers reduced Pol III transcriptional activity compared to RPC7α (POLR3G), linked to differences in their C-terminal domain architecture.","method":"Review synthesizing structural and genomic studies (including published cryo-EM structures and ChIP-seq data from multiple labs)","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — synthesis of structural and genomic evidence from multiple independent studies, though this specific paper is a review","pmids":["34850129"],"is_preprint":false}],"current_model":"POLR3GL encodes RPC7β, one of two mutually exclusive alternative subunits (the other being POLR3G/RPC7α) that define two isoforms of RNA polymerase III in vertebrates; both isoforms occupy the same target genes but POLR3GL-containing Pol III has reduced transcriptional activity at a subset of targets (notably snaR-A), POLR3GL expression is ubiquitous and increases during differentiation while POLR3G is enriched in proliferating/stem/cancer cells, the two subunits can functionally compensate for each other in vivo though total Pol III levels constrain this compensation, and biallelic loss-of-function variants in POLR3GL cause Pol III-related developmental disorders including endosteal hyperostosis, oligodontia, and a neonatal progeroid syndrome variant."},"narrative":{"mechanistic_narrative":"POLR3GL encodes RPC7β, one of two mutually exclusive alternative subunits that define distinct isoforms of RNA polymerase III in vertebrates, the other being the paralog POLR3G (RPC7α) which arose from the same ancestral DNA-based gene duplication [PMID:24107381, PMID:34850129]. POLR3GL- and POLR3G-containing Pol III complexes occupy the same target genes in constant proportions and perform the same core transcriptional function in vitro and in vivo, but the two isoforms acquired distinct regulation and differential output: the POLR3GL promoter does not bind MYC, and POLR3GL-containing Pol III displays reduced transcriptional activity at a subset of targets — notably the snaR-A noncoding RNA — relative to the more active POLR3G isoform, a difference linked to RPC7 C-terminal domain architecture [PMID:24107381, PMID:35637192, PMID:34850129]. This isoform composition acts as a regulatory determinant of cell fate: POLR3GL is upregulated during differentiation (including Xenopus skeletal myogenesis) while POLR3G predominates in proliferating cells, and the two subunits influence the synthesis of specific tRNA isoacceptors [PMID:31173763, PMID:35637192]. The subunits functionally compensate in vivo — exogenous POLR3GL rescues the differentiation defect of POLR3G-knockout ESCs — but compensation is constrained by total Pol III levels, since POLR3GL-knockout mice complete embryogenesis yet die ~3 weeks after birth with growth and cerebellar defects attributed to insufficient total Pol III rather than a unique POLR3GL function [PMID:32576691]. Biallelic loss-of-function variants in POLR3GL cause Pol III-related developmental disorders, including endosteal hyperostosis with oligodontia and a neonatal progeroid syndrome variant [PMID:31089205, PMID:31695177].","teleology":[{"year":2013,"claim":"Established whether the two RPC7 paralogs build functionally divergent Pol III complexes or merely differ in their own regulation, by mapping where each isoform binds genome-wide.","evidence":"Genome-wide ChIP-seq, evolutionary genomic analysis, and promoter-MYC binding analysis in a cell line","pmids":["24107381"],"confidence":"High","gaps":["Same occupancy does not establish equal transcriptional output at occupied genes","MYC absence at the POLR3GL promoter not linked to a downstream functional consequence","Tested in a single cell line"]},{"year":2019,"claim":"Showed POLR3GL and POLR3G are not interchangeable in cell-fate control, since depleting each subunit produced opposite phenotypic consequences in cancer cells.","evidence":"siRNA depletion with proliferation/differentiation readouts in prostate cancer lines","pmids":["30820548"],"confidence":"Medium","gaps":["Mechanism linking POLR3GL depletion to its lack of phenotype unresolved","Knockdown not whole-organism; single lineage"]},{"year":2019,"claim":"Linked Pol III isoform identity to tRNA output and differentiation by showing reciprocal expression and distinct tRNA isoacceptor activities of the two subunits during myogenesis.","evidence":"Custom tRNA microarray and overexpression rescue in Xenopus myogenic differentiation","pmids":["31173763"],"confidence":"Medium","gaps":["Specific tRNA isoacceptors driving the fate switch not pinned to phenotype","Ortholog system; mammalian generalization untested here"]},{"year":2019,"claim":"Established POLR3GL as a disease-causing Pol III subunit by tying biallelic loss-of-function to endosteal hyperostosis and oligodontia with transcript-level confirmation.","evidence":"Whole exome and RNA sequencing validating splice-acceptor loss-of-function in patients","pmids":["31089205"],"confidence":"Medium","gaps":["Molecular path from Pol III deficiency to bone/dental phenotype not defined","Single study cohort"]},{"year":2019,"claim":"Broadened the POLR3GL disease spectrum by linking a homozygous nonsense allele undergoing NMD to a neonatal progeroid syndrome variant.","evidence":"Exome sequencing with RNA-level NMD confirmation in a patient","pmids":["31695177"],"confidence":"Medium","gaps":["Single case report","Mechanism connecting null allele to progeroid features unknown"]},{"year":2020,"claim":"Resolved whether POLR3GL has a unique essential function or acts as a quantitative contributor to Pol III, using knockout mice and ESC rescue.","evidence":"Conditional/constitutive knockout mice, in vitro transcription, ChIP-seq, and ESC differentiation rescue","pmids":["32576691"],"confidence":"High","gaps":["Why postnatal lethality occurs despite completed embryogenesis not fully explained","Cerebellar neuronal defect described as potential, not mechanistically dissected"]},{"year":2022,"claim":"Defined the functional asymmetry between the isoforms by showing POLR3G loss restricts the Pol III repertoire (especially snaR-A) while POLR3GL loss does not, marking isoform identity as a transcriptional regulatory mechanism.","evidence":"POLR3G knockout/depletion with ChIP-seq, RNA-seq, and isoform occupancy genomics","pmids":["35637192"],"confidence":"High","gaps":["Structural basis for reduced POLR3GL activity not directly tested here","Physiological role of snaR-A sensitivity unresolved"]},{"year":2021,"claim":"Synthesized structural and genomic evidence attributing the reduced activity of the POLR3GL (RPC7β) isoform to C-terminal domain differences between the two alternate subunits.","evidence":"Review integrating cryo-EM structures and ChIP-seq data from multiple labs","pmids":["34850129"],"confidence":"Medium","gaps":["Causal link between C-terminal architecture and activity not demonstrated by direct mutagenesis here","Review-level synthesis rather than primary data"]},{"year":null,"claim":"It remains unknown how the POLR3GL-specific reduction in Pol III activity at targets like snaR-A is converted into the tissue-specific developmental phenotypes of bone, teeth, and progeroid disease.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No direct mechanistic chain from isoform-specific transcript changes to organ phenotypes","C-terminal domain function not tested by targeted mutation in vivo","Tissue specificity of compensation by POLR3G not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,4,6]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[4,7]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,4]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,6]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,3]}],"complexes":["RNA polymerase III"],"partners":["POLR3G"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9BT43","full_name":"DNA-directed RNA polymerase III subunit RPC7-like","aliases":["DNA-directed RNA polymerase III subunit G-like","RNA polymerase III 32 kDa beta subunit","RPC32-beta"],"length_aa":218,"mass_kda":25.3,"function":"DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9BT43/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POLR3GL","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000121851","cell_line_id":"CID000716","localizations":[{"compartment":"nuclear_punctae","grade":3},{"compartment":"nucleoplasm","grade":2}],"interactors":[{"gene":"POLR2K","stoichiometry":10.0},{"gene":"POLR3B","stoichiometry":10.0},{"gene":"POLR3E","stoichiometry":10.0},{"gene":"POLR3F","stoichiometry":10.0},{"gene":"POLR3D","stoichiometry":10.0},{"gene":"POLR3A","stoichiometry":10.0},{"gene":"POLR2E","stoichiometry":10.0},{"gene":"POLR3C","stoichiometry":10.0},{"gene":"CRCP","stoichiometry":4.0},{"gene":"POLR2H","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000716","total_profiled":1310},"omim":[{"mim_id":"619234","title":"SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM","url":"https://www.omim.org/entry/619234"},{"mim_id":"617457","title":"POLYMERASE III, RNA, SUBUNIT G-LIKE; POLR3GL","url":"https://www.omim.org/entry/617457"},{"mim_id":"617456","title":"POLYMERASE III, RNA, SUBUNIT G; POLR3G","url":"https://www.omim.org/entry/617456"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLR3GL"},"hgnc":{"alias_symbol":["flj32422","MGC3200"],"prev_symbol":[]},"alphafold":{"accession":"Q9BT43","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BT43","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BT43-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BT43-F1-predicted_aligned_error_v6.png","plddt_mean":71.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLR3GL","jax_strain_url":"https://www.jax.org/strain/search?query=POLR3GL"},"sequence":{"accession":"Q9BT43","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BT43.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BT43/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BT43"}},"corpus_meta":[{"pmid":"34395528","id":"PMC_34395528","title":"RNA Polymerase III Subunit Mutations in Genetic Diseases.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/34395528","citation_count":55,"is_preprint":false},{"pmid":"24107381","id":"PMC_24107381","title":"Gene duplication and neofunctionalization: POLR3G and POLR3GL.","date":"2013","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/24107381","citation_count":46,"is_preprint":false},{"pmid":"30820548","id":"PMC_30820548","title":"Effects on prostate cancer cells of targeting RNA polymerase III.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30820548","citation_count":38,"is_preprint":false},{"pmid":"34850129","id":"PMC_34850129","title":"The nuclear and cytoplasmic activities of RNA polymerase III, and an evolving transcriptome for surveillance.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34850129","citation_count":34,"is_preprint":false},{"pmid":"31089205","id":"PMC_31089205","title":"Biallelic variants in POLR3GL cause endosteal hyperostosis and oligodontia.","date":"2019","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/31089205","citation_count":31,"is_preprint":false},{"pmid":"35637192","id":"PMC_35637192","title":"A cancer-associated RNA polymerase III identity drives robust transcription and expression of snaR-A noncoding RNA.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35637192","citation_count":28,"is_preprint":false},{"pmid":"32576691","id":"PMC_32576691","title":"Functions of paralogous RNA polymerase III subunits POLR3G and POLR3GL in mouse development.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32576691","citation_count":27,"is_preprint":false},{"pmid":"31695177","id":"PMC_31695177","title":"A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL.","date":"2019","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/31695177","citation_count":24,"is_preprint":false},{"pmid":"36497214","id":"PMC_36497214","title":"The POLR3G Subunit of Human RNA Polymerase III Regulates Tumorigenesis and Metastasis in Triple-Negative Breast Cancer.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36497214","citation_count":16,"is_preprint":false},{"pmid":"34447748","id":"PMC_34447748","title":"Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34447748","citation_count":15,"is_preprint":false},{"pmid":"37338518","id":"PMC_37338518","title":"Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37338518","citation_count":14,"is_preprint":false},{"pmid":"31173763","id":"PMC_31173763","title":"Skeletal muscle differentiation drives a dramatic downregulation of RNA polymerase III activity and differential expression of Polr3g isoforms.","date":"2019","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31173763","citation_count":10,"is_preprint":false},{"pmid":"36710885","id":"PMC_36710885","title":"RNA polymerase III transcription and cancer: A tale of two RPC7 subunits.","date":"2023","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36710885","citation_count":8,"is_preprint":false},{"pmid":"37894362","id":"PMC_37894362","title":"A Combinatorial Regulatory Platform Determines Expression of RNA Polymerase III Subunit RPC7α (POLR3G) in Cancer.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37894362","citation_count":4,"is_preprint":false},{"pmid":"40684265","id":"PMC_40684265","title":"Comprehensive genotype-phenotype analysis in POLR3-related disorders.","date":"2025","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/40684265","citation_count":3,"is_preprint":false},{"pmid":"40777011","id":"PMC_40777011","title":"Optimized network inference for immune diseased single cells.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40777011","citation_count":0,"is_preprint":false},{"pmid":"38796765","id":"PMC_38796765","title":"[Wiedemann-Rautenstrauch syndrome. The first description of a clinical case in the Russian Federation].","date":"2023","source":"Problemy endokrinologii","url":"https://pubmed.ncbi.nlm.nih.gov/38796765","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9645,"output_tokens":2164,"usd":0.030697,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9254,"output_tokens":2926,"usd":0.05971,"stage2_stop_reason":"end_turn"},"total_usd":0.090407,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"POLR3GL and POLR3G arose from a DNA-based gene duplication in a common ancestor of vertebrates. Both POLR3GL-containing and POLR3G-containing Pol III complexes occupy the same target genes in very constant proportions within one cell line (by ChIP-seq), indicating that the two Pol III isoforms share the same target gene specificity. The POLR3GL promoter does not bind MYC (unlike the POLR3G promoter), indicating that POLR3G and POLR3GL acquired distinct transcriptional regulatory mechanisms (neofunctionalization at the transcription unit level, not at the level of the gene product's target specificity).\",\n      \"method\": \"Genome-wide ChIP-seq, evolutionary genomic analysis, promoter-MYC binding analysis\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq with multiple orthogonal methods (ChIP-seq, evolutionary analysis, promoter binding assays) in a focused mechanistic study\",\n      \"pmids\": [\"24107381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Depletion of POLR3GL does not trigger proliferative arrest or differentiation of prostate cancer cells, in contrast to depletion of the paralog POLR3G, demonstrating that POLR3GL and POLR3G have functionally distinct roles in controlling cancer cell fate despite both being incorporated into Pol III.\",\n      \"method\": \"siRNA depletion / knockdown with proliferation and differentiation phenotypic readouts in prostate cancer cell lines\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockdown with specific cellular phenotype readouts, single lab, two subunits compared in parallel\",\n      \"pmids\": [\"30820548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Biallelic loss-of-function splice acceptor site variants in POLR3GL confirmed by RNA sequencing (showing loss of full-length POLR3GL transcripts) cause endosteal hyperostosis and oligodontia, establishing POLR3GL as a disease-causing subunit of the Pol III complex.\",\n      \"method\": \"Whole exome sequencing, RNA sequencing (nonsense-mediated decay / splice variant validation) in patient blood samples\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA sequencing confirmed loss-of-function at transcript level; single study but uses orthogonal molecular validation\",\n      \"pmids\": [\"31089205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A homozygous nonsense variant in POLR3GL (p.Arg120Ter) leads to nonsense-mediated decay of POLR3GL transcripts (confirmed by RNA studies), establishing that complete loss of POLR3GL function causes a variant of neonatal progeroid syndrome.\",\n      \"method\": \"Exome sequencing and RNA analysis (NMD confirmation) in patient sample\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — RNA-level NMD confirmation in patient sample, single case report with molecular validation\",\n      \"pmids\": [\"31695177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POLR3GL-containing Pol III (Pol IIIβ) and POLR3G-containing Pol III (Pol IIIα) bind the same target genes and perform the same function both in vitro and in vivo. POLR3GL can compensate for loss of POLR3G: exogenous POLR3GL expression rescues the differentiation defect of POLR3G knockout ESCs. POLR3GL knockout mice complete embryonic development but die at ~3 weeks after birth with growth defects and potential cerebellar neuronal defects, attributed to insufficient total Pol III rather than a unique POLR3GL function.\",\n      \"method\": \"Conditional and constitutive knockout mouse models, in vitro transcription assays, ChIP-seq, ESC differentiation rescue experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro assays, in vivo knockout models, and rescue experiments with multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"32576691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"During Xenopus skeletal muscle differentiation, Polr3gL (POLR3GL ortholog) is upregulated alongside contractile protein genes, whereas Polr3g is downregulated. Using a custom tRNA microarray, Polr3g and Polr3gL were shown to have distinct activities on the synthesis of specific tRNA isoacceptors. Forced Polr3g expression partially reverses myogenic differentiation, placing Pol III isoform composition as a regulatory determinant of muscle cell fate.\",\n      \"method\": \"Custom tRNA microarray, overexpression rescue experiments in Xenopus myogenic differentiation model\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional tRNA microarray plus overexpression phenotype in developmental model, single lab, two orthogonal approaches\",\n      \"pmids\": [\"31173763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss of POLR3G (but not POLR3GL) results in a restricted Pol III transcriptional repertoire, with snaR-A noncoding RNA being particularly sensitive to POLR3G loss. This establishes that POLR3G-containing Pol III has enhanced transcriptional activity at a specific subset of targets compared to POLR3GL-containing Pol III, identifying Pol III isoform identity as a transcriptional regulatory mechanism.\",\n      \"method\": \"POLR3G knockout/depletion, ChIP-seq, RNA-seq, genomic analysis of Pol III isoform occupancy\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal isoform genomics with ChIP-seq and RNA-seq, multiple orthogonal methods establishing differential activity of the two isoforms\",\n      \"pmids\": [\"35637192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"POLR3GL (as RPC7β) is one of two alternate subunits that define distinct vertebrate Pol III isoforms; structural and genomic studies indicate RPC7β (POLR3GL) confers reduced Pol III transcriptional activity compared to RPC7α (POLR3G), linked to differences in their C-terminal domain architecture.\",\n      \"method\": \"Review synthesizing structural and genomic studies (including published cryo-EM structures and ChIP-seq data from multiple labs)\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — synthesis of structural and genomic evidence from multiple independent studies, though this specific paper is a review\",\n      \"pmids\": [\"34850129\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLR3GL encodes RPC7β, one of two mutually exclusive alternative subunits (the other being POLR3G/RPC7α) that define two isoforms of RNA polymerase III in vertebrates; both isoforms occupy the same target genes but POLR3GL-containing Pol III has reduced transcriptional activity at a subset of targets (notably snaR-A), POLR3GL expression is ubiquitous and increases during differentiation while POLR3G is enriched in proliferating/stem/cancer cells, the two subunits can functionally compensate for each other in vivo though total Pol III levels constrain this compensation, and biallelic loss-of-function variants in POLR3GL cause Pol III-related developmental disorders including endosteal hyperostosis, oligodontia, and a neonatal progeroid syndrome variant.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POLR3GL encodes RPC7β, one of two mutually exclusive alternative subunits that define distinct isoforms of RNA polymerase III in vertebrates, the other being the paralog POLR3G (RPC7α) which arose from the same ancestral DNA-based gene duplication [#0, #7]. POLR3GL- and POLR3G-containing Pol III complexes occupy the same target genes in constant proportions and perform the same core transcriptional function in vitro and in vivo, but the two isoforms acquired distinct regulation and differential output: the POLR3GL promoter does not bind MYC, and POLR3GL-containing Pol III displays reduced transcriptional activity at a subset of targets — notably the snaR-A noncoding RNA — relative to the more active POLR3G isoform, a difference linked to RPC7 C-terminal domain architecture [#0, #6, #7]. This isoform composition acts as a regulatory determinant of cell fate: POLR3GL is upregulated during differentiation (including Xenopus skeletal myogenesis) while POLR3G predominates in proliferating cells, and the two subunits influence the synthesis of specific tRNA isoacceptors [#5, #6]. The subunits functionally compensate in vivo — exogenous POLR3GL rescues the differentiation defect of POLR3G-knockout ESCs — but compensation is constrained by total Pol III levels, since POLR3GL-knockout mice complete embryogenesis yet die ~3 weeks after birth with growth and cerebellar defects attributed to insufficient total Pol III rather than a unique POLR3GL function [#4]. Biallelic loss-of-function variants in POLR3GL cause Pol III-related developmental disorders, including endosteal hyperostosis with oligodontia and a neonatal progeroid syndrome variant [#2, #3].\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Established whether the two RPC7 paralogs build functionally divergent Pol III complexes or merely differ in their own regulation, by mapping where each isoform binds genome-wide.\",\n      \"evidence\": \"Genome-wide ChIP-seq, evolutionary genomic analysis, and promoter-MYC binding analysis in a cell line\",\n      \"pmids\": [\"24107381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Same occupancy does not establish equal transcriptional output at occupied genes\",\n        \"MYC absence at the POLR3GL promoter not linked to a downstream functional consequence\",\n        \"Tested in a single cell line\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed POLR3GL and POLR3G are not interchangeable in cell-fate control, since depleting each subunit produced opposite phenotypic consequences in cancer cells.\",\n      \"evidence\": \"siRNA depletion with proliferation/differentiation readouts in prostate cancer lines\",\n      \"pmids\": [\"30820548\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism linking POLR3GL depletion to its lack of phenotype unresolved\",\n        \"Knockdown not whole-organism; single lineage\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked Pol III isoform identity to tRNA output and differentiation by showing reciprocal expression and distinct tRNA isoacceptor activities of the two subunits during myogenesis.\",\n      \"evidence\": \"Custom tRNA microarray and overexpression rescue in Xenopus myogenic differentiation\",\n      \"pmids\": [\"31173763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific tRNA isoacceptors driving the fate switch not pinned to phenotype\",\n        \"Ortholog system; mammalian generalization untested here\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established POLR3GL as a disease-causing Pol III subunit by tying biallelic loss-of-function to endosteal hyperostosis and oligodontia with transcript-level confirmation.\",\n      \"evidence\": \"Whole exome and RNA sequencing validating splice-acceptor loss-of-function in patients\",\n      \"pmids\": [\"31089205\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular path from Pol III deficiency to bone/dental phenotype not defined\",\n        \"Single study cohort\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Broadened the POLR3GL disease spectrum by linking a homozygous nonsense allele undergoing NMD to a neonatal progeroid syndrome variant.\",\n      \"evidence\": \"Exome sequencing with RNA-level NMD confirmation in a patient\",\n      \"pmids\": [\"31695177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single case report\",\n        \"Mechanism connecting null allele to progeroid features unknown\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved whether POLR3GL has a unique essential function or acts as a quantitative contributor to Pol III, using knockout mice and ESC rescue.\",\n      \"evidence\": \"Conditional/constitutive knockout mice, in vitro transcription, ChIP-seq, and ESC differentiation rescue\",\n      \"pmids\": [\"32576691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Why postnatal lethality occurs despite completed embryogenesis not fully explained\",\n        \"Cerebellar neuronal defect described as potential, not mechanistically dissected\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined the functional asymmetry between the isoforms by showing POLR3G loss restricts the Pol III repertoire (especially snaR-A) while POLR3GL loss does not, marking isoform identity as a transcriptional regulatory mechanism.\",\n      \"evidence\": \"POLR3G knockout/depletion with ChIP-seq, RNA-seq, and isoform occupancy genomics\",\n      \"pmids\": [\"35637192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for reduced POLR3GL activity not directly tested here\",\n        \"Physiological role of snaR-A sensitivity unresolved\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Synthesized structural and genomic evidence attributing the reduced activity of the POLR3GL (RPC7β) isoform to C-terminal domain differences between the two alternate subunits.\",\n      \"evidence\": \"Review integrating cryo-EM structures and ChIP-seq data from multiple labs\",\n      \"pmids\": [\"34850129\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Causal link between C-terminal architecture and activity not demonstrated by direct mutagenesis here\",\n        \"Review-level synthesis rather than primary data\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how the POLR3GL-specific reduction in Pol III activity at targets like snaR-A is converted into the tissue-specific developmental phenotypes of bone, teeth, and progeroid disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct mechanistic chain from isoform-specific transcript changes to organ phenotypes\",\n        \"C-terminal domain function not tested by targeted mutation in vivo\",\n        \"Tissue specificity of compensation by POLR3G not mapped\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 4, 6]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [\"RNA polymerase III\"],\n    \"partners\": [\"POLR3G\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}